Drug · DIN 02478196
PHARMA-LACOSAMIDE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 1, 2018; first marketed October 1, 2018.
- Drug Identification Number (DIN)
- 02478196
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lacosamide N03AX18
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LACOSAMIDE | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2018: NOC 21375Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named PHARMA-LACOSAMIDE
- DIN 02478218 · Marketed
- DIN 02478226 · Marketed
- DIN 02478234 · Marketed